<i>Nkapl</i> deletion drives cognitive deficits through mPFC interneuron dysfunction in a mouse model of schizophrenia.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41032616.
- Also identified by DOI 10.1126/sciadv.adv4779 and PMC identifier 12487883.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cognitive dysfunction is a core feature of schizophrenia (SCZ), yet its mechanisms remain poorly understood. We investigated the functional role of <i>NKAPL</i> (nuclear factor κB activating protein-like)-an SCZ risk-associated gene-and the single nucleotide polymorphism rs1635 in cognitive deficits related to SCZ. We used <i>Nkapl</i> transgenic mouse models to explore the impact of <i>NKAPL</i> on SCZ-related cognitive deficits. NKAPL acts as a transcriptional repressor of the γ-aminobutyric acid (GABA) metabolizing enzyme succinic semialdehyde dehydrogenase (SSADH). <i>Nkapl</i> deletion in medial prefrontal cortex (mPFC) interneurons led to increased SSADH levels, reduced GABA concentration in the synaptic cleft, impaired inhibitory synaptic transmission, and cognitive deficits. Furthermore, the rs1635 mutation (T153N) caused similar effects as the <i>Nkapl</i> knockout. Reexpression of wild-type NKAPL or genetic knockdown of SSADH in mPFC interneurons restored the synaptic dysfunction and cognitive deficits in <i>Nkapl</i><sup>-/-</sup> mice. Our study indicates the potential role of NKAPL and SSADH in mPFC interneurons in neuronal mechanisms of learning and memory in mice.
Medical subject headings
- Schizophrenia
- Interneurons
- Cognitive Dysfunction
- Prefrontal Cortex
- Gene Deletion
- Repressor Proteins